Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	31.17	73.98	50.71	71.72	9.77
Short-Term Investments	73.94	22.52	106.51	149.68	54.38
Cash & Cash Equivalents	105.11	96.5	157.22	221.4	64.16
Cash Growth	8.92%	-38.62%	-28.99%	245.09%	-35.79%
Receivables	12.1	0	0	0	8.28
Inventory	10.38	0	0	0	3.57
Other Current Assets	6.61	4.34	35.27	42.05	6.37
Total Current Assets	134.2	100.84	192.49	263.45	82.38
Property, Plant & Equipment	3.18	2.55	2.94	2.96	4.16
Goodwill and Intangibles	16.84	16.84	16.84	16.84	19.3
Other Long-Term Assets	10.48	12.55	35	28.38	45.6
Total Long-Term Assets	30.5	31.94	54.78	48.18	69.06
Total Assets	164.7	132.79	247.27	311.64	151.44
Accounts Payable	11.43	7.89	7.68	2.93	6.1
Current Debt	0.93	38.63	0.9	0.47	0.65
Other Current Liabilities	24.49	9.28	12.42	11.7	29.24
Total Current Liabilities	36.86	55.79	21	15.11	35.98
Long-Term Debt	34.45	92.39	144.1	130.05	124.01
Other Long-Term Liabilities	5.65	5.74	3.92	4.21	20.65
Total Long-Term Liabilities	40.1	98.14	148.02	134.26	144.65
Total Liabilities	76.96	153.93	169.02	149.37	180.64
Total Debt	35.38	131.02	145	130.52	124.65
Debt Growth	-72.99%	-9.64%	11.09%	4.71%	-7.83%
Retained Earnings	-745.5	-585.22	-447.76	-384.19	-391.22
Comprehensive Income	-23.17	-26.34	-23.94	-21.05	-22.81
Shareholders' Equity	87.74	-21.15	78.24	162.27	-29.2
Net Cash / Debt	69.73	-34.52	12.22	90.88	-60.49
Net Cash / Debt Growth	-	-	-86.56%	-	-
Net Cash Per Share	0.87	-0.57	0.21	1.65	-1.62
Working Capital	97.35	45.05	171.49	248.35	46.4
Book Value Per Share	1.09	-0.35	1.34	3.06	-0.78

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).